San Jose, CA — Jan Marini Skin Research (JMSR; JanMarini.com), a leading provider of professional skin care and aesthetic solutions, announced the shipment of four new technologies to address the appearance of photo-aging and hyperpigmentation. Age Intervention Enlighten MD and Age Intervention Enlighten Plus are two new concentrated non-hydroquinone solutions available as both stand-alone products and integrated into new expanded versions of the award winning Skin Care Management System (SCMS). The new systems, SCMS Plus and SCMS MD, are available in normal, dry and oily to meet the needs of all skin types.
Age Intervention Enlighten Plus and Enlighten MD are two new anti-aging and pigmentation solutions comprising high concentrations of both retinol and multiple proven non-hydroquinone based Tyrosinase inhibitors. Tyrosinase inhibitors are the most effective and proven technology to reduce hyperpigmentation. Both products use the original and popular Age Intervention Enlighten (2008) as a base and then enhance it by introducing additional Tyrosinase inhibitors and increasing the concentrations of select key ingredients. The result is a significantly more concentrated product with a 50% increase in the concentration of brightening technologies. The combination of technologies in Age Intervention Enlighten Plus and Enlighten MD make them new standards for non-hydroquinone based pigment and anti-aging products.
Dr. Jacqueline Calkin, Board Certified Dermatologist, stated, "In our experience using Enlighten MD and the SCMS MD, the appearance of hyperpigmentation from sun damage and melasma decreased significantly and rapidly. Further, patients also experienced significant improvement in the appearance of fine lines and wrinkles, erythema, rosacea, photo-aging, acne, textural issues and overall skin quality. I've found the results to be comparable to those achieved with a combination of prescription topical solutions without the common challenges of a patient acclimation period which commonly includes several weeks of skin irritation flaking or peeling. In fact, in our study experience, use of the SCMS appears to actually decrease irritation and flaking associated with prescription topical tretinoin. After testing and personally using the new SCMS I am extremely satisfied with the products, the results and the overall quality my patient's skin."
Age Intervention Enlighten Plus and Enlighten MD are being marketed for immediate sale to the professionally dispensed skincare marketplace by JMSR. Age Intervention Enlighten MD, which includes a higher concentration of retinol, is only available for sale through physician offices. Age Intervention Enlighten Plus and Enlighten MD along with JMSR's Gentle Cleanser are available in the new Plus and MD versions of the award winning SCMS.
Jan Marini, President & CEO stated, "The release of these four new products uniquely positions JMSR in today's professional skin care market with the most complete award winning skin care system designed address two of today's most significant skin concerns— the appearance of wrinkles and discoloration. We are extremely excited by the opportunity presented by these great new products. Furthermore, we are confident that the expansion of our physician only MD line will significantly enhance JMSR's profile and success in the growing physician office market."
About Jan Marini Skin Research, Inc.
San Jose, CA-based Jan Marini Skin Research, Inc. (JMSR) is a recognized leader and innovator in skin care committed to continually expanding and improving the professional skin care market. JMSR's commitment is shown through a track-record of technological firsts including, but not limited to, topical TGF beta-1, antioxidant sunscreen, topical resveratrol and cosmetic lash enhancement. JMSR products and its Skin Care Management System are used and trusted by physicians and skin care professionals worldwide to ensure optimum results for their patients and clients.
For more information about Jan Marini Skin Research, please contact our Public Relations department.